Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Is The Expected Total Market Size Of The Cancer Therapy Industry By The Forecast Year 2029?
The cancer therapy market size has experienced rapid expansion in recent years. It is projected to increase from $190.44 billion in 2024 to $210.44 billion in 2025, achieving a compound annual growth rate (CAGR) of 10.5%. The historical growth of this market stems from factors such as the increasing global incidence of cancer, the rising acceptance of chemotherapy treatments, heightened awareness regarding early cancer diagnosis, an increase in the availability of oncology specialists, and improved access to hospital-based treatment services.
The cancer therapy market is projected to experience substantial expansion in the coming years. This market is anticipated to reach $310.85 billion by 2029, showing a compound annual growth rate (CAGR) of 10.2%. This expansion during the projection period stems from factors such as increasing demand for tailored cancer treatments, a heightened emphasis on outpatient cancer services, the growing embrace of immunotherapy, broadened healthcare access in developing nations, and the rising prevalence of cancers linked to lifestyle choices. Key trends anticipated for this period encompass technological progress in cancer diagnosis, breakthroughs in targeted medication delivery, significant investment in the research and development of biologics, the creation of AI-driven treatment strategies, and advancements in less invasive cancer surgical procedures.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24492&type=smp
Which Drivers Are Supporting Growth Of The Cancer Therapy Market?
The increasing occurrence of cancer is projected to stimulate expansion in the cancer therapy market going forward. Cancer encompasses a collection of illnesses defined by the unchecked proliferation and dissemination of atypical cells throughout the body. The uptick in cancer cases is largely attributable to greater exposure to environmental cancer-causing agents like pollution and tobacco smoke. Critical for addressing the growing incidence of cancer, cancer therapy involves treating existing patients, enhancing survival outcomes, and slowing the disease’s advancement. For example, data from February 2024 released by the World Health Organization (WHO), an intergovernmental body based in Switzerland, predicts that worldwide cancer cases will surpass 35 million annually by 2050. This signifies a 77% surge compared to the approximately 20 million cases documented in 2022. Consequently, the growing frequency of cancer is a primary catalyst for the cancer therapy market.
Which Key Segments Fueling The Cancer Therapy Market?
The cancer therapy market covered in this report is segmented –
1) By Therapy Type: Chemotherapy, Target Therapy, Immunotherapy, Radiotherapy, Other Therapy Types
2) By Cancer Type: Blood Cancer, Breast Cancer, Prostate Cancer, Gastrointestinal Cancer, Gynaecologic Cancer, Respiratory Or Lung Cancer, Other Cancer Types
3) By End User: Hospitals, Specialty Clinics, Cancer And Radiation Therapy Centers
Subsegment:
1) By Chemotherapy: Alkylating Agents, Antimetabolites, Anti-Tumor Antibiotics, Topoisomerase Inhibitors, Mitotic Inhibitors, Corticosteroids, Other Chemotherapy Drugs
2) By Targeted Therapy: Monoclonal Antibodies, Tyrosine Kinase Inhibitors (TKIs), mTOR Inhibitors, Proteasome Inhibitors, PARP Inhibitors, Other Targeted Agents
3) By Immunotherapy: Immune Checkpoint Inhibitors, CAR T-cell Therapy, Cancer Vaccines, Cytokines, Oncolytic Virus Therapy, Other Immunotherapies
4) By Radiotherapy: External Beam Radiation Therapy (EBRT), Internal Radiation Therapy (Brachytherapy), Systemic Radiation Therapy, Stereotactic Radiosurgery (SRS), Intensity-Modulated Radiation Therapy (IMRT), Image-Guided Radiation Therapy (IGRT)
5) By Other Therapy Types: Hormone Therapy, Stem Cell Transplant, Photodynamic Therapy, Cryoablation, Hyperthermia Therapy
What Are The Latest Industry Trends Transforming The Cancer Therapy Market?
Leading companies in the cancer therapy market are concentrating on developing novel therapies, such as immuno-oncology drugs, to improve treatment effectiveness by utilizing the body’s immune system to target and destroy cancer cells. Immuno-oncology drugs are a type of cancer treatment that stimulates or enhances the body’s own immune system to more effectively recognize and attack cancer cells. For example, in December 2024, Dr. Reddy’s Laboratories Ltd., an India-based pharmaceutical company, launched Toripalimab in India; this is the first and only immuno-oncology medication approved for treating nasopharyngeal cancer. This launch offers a new, targeted treatment choice for patients suffering from this rare and aggressive cancer, potentially leading to better outcomes through advanced immune system engagement. The availability of toripalimab in India emphasizes Dr. Reddy’s commitment to increasing access to cutting-edge cancer therapies in underserved regions.
Which Leading Companies Dominate The Cancer Therapy Market Share?
Major companies operating in the cancer therapy market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd, Merck & Co. Inc., Bayer Aktiengesellschaft, Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis International AG, GlaxoSmithKline PLC, Elekta AB, Exelixis Inc., Accuray Incorporated, Akeso Inc., Nanobiotix S.A., SOTIO Biotech a.s., AdvanCell Isotopes Pty Ltd, Axcynsis Therapeutics Pte Ltd, Clarity Pharmaceuticals Ltd, Affimed N.V., Aptadel Therapeutics S.L.
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/cancer-therapy-global-market-report
Which Region Currently Holds The Largest Share Of The Cancer Therapy Market?
North America was the largest region in the cancer therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Cancer Therapy Market Report:
https://www.thebusinessresearchcompany.com/customise?id=24492&type=smp
Browse Through More Reports Similar to the Global Cancer Therapy Market 2025, By The Business Research Company
Oncology Drugs Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/oncology-drugs-global-market-report
Blood Cancer Drugs Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/blood-cancer-drugs-global-market-report
Cancer Immunotherapy Drug Discovery Outsourcing Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
